Experts share here what they take away from the Conference on Retroviruses and Opportunistic Infections (CROI) each year and ...

Switching to long-acting ART from oral treatments was cost effective for postpartum women with HIV and improved infant ...

There were empty seats in San Francisco last week at an annual international science conference which has delivered some of the world's most groundbreaking HIV research. It was a throwback to another ...

Increasing HPV vaccination rates could help decrease the number of cancer cases “attributable to HIV,” according to data from ...

Gilead Sciences, Inc. (NASDAQ:GILD) presented data from its HIV treatment portfolio and pipeline at the Conference on ...

AIDS advocates are fearful that budget cuts being pushed by Republicans will gut essential health care services in the United ...

News reporting will resume with coverage of the Conference on Retroviruses and Opportunistic Infections (CROI), being held in San Francisco from 9 to 12 March. Our reporting team from CROI are Keith ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of late-breaking data and multiple oral presentations ...

In 2020, the Conference on Retroviruses and Opportunistic Infections (CROI) was the first scientific conference to move from in-person to virtual due to the COVID-19 pandemic. On the fifth anniversary ...

Researchers from the HIV Prevention Trials Network (HPTN) presented results from the HPTN 094 (“INTEGRA”) study at the 2025 ...